Axelpharm demands a license for anti-cancer drug from AstraZeneca
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...